The renowned track cyclist and Olympic medalist Chris Hoy recently revealed that he was diagnosed with terminal prostate cancer. Although he did not provide specific details about his diagnosis, Hoy reported that the disease was discovered in September 2023, after seeking treatment for what he initially believed was a shoulder injury, according to the Sunday Times.
After a series of tests, scans revealed that the cancer had spread to several parts of his body, such as the shoulder, hip, pelvis, spine, and ribs, leading doctors to declare it incurable and potentially fatal within a span of two to four years.
Prostate cancer is a common type of malignant tumor that affects men in the European Union, being more frequent in individuals over 65 years old. The symptoms of this disease often do not manifest in its early stages, but in more advanced phases, the patient may experience difficulties urinating, blood in urine or semen, pain in various areas of the body, erectile dysfunction, among others.
To detect prostate cancer, blood tests can be performed to measure PSA (prostate-specific antigen), a protein produced by prostate cells. Although this method is not recommended generally, there are other factors such as age, race, family history, among others, that may indicate a higher risk of developing this disease.
In the presence of any symptoms related to prostate cancer, it is advised to consult a doctor for an accurate diagnosis and to rule out other possible causes. Early detection of this type of cancer is crucial to increase the chances of treatment and patient survival.
